Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous diseases caused by monoclonal immunoglobulin and/or free light chains (monoclonal gammopathy of cutaneous significance).

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Changes in hemostasis and other disorders caused by monoclonal immunoglobulin and/or free light chains.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Treatment of Castleman disease from the perspective of the year 2026.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Polyclonal hypergammaglobulinemia, infiltration of the salivary glands, lymphadenopathy, and kidney damage - Mikulicz's disease, Sjögren's syndrome, or Castleman's disease? Case report and overview of differential diagnosis and treatment.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same author

Monoclonal gammopathy of clinical significance - a group name for diseases caused by monoclonal immunoglobulin and/ or free light chains. A change in the approach to non-malignant gammopathies.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same author

Precision medicine in hemato-oncology - treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/ MEK inhibitors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2025
Same journal

68Ga-DOTATOC PET/CT - a case report of synchronous oncological duplicity with high expression of somatostatin receptors.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Differences in the imaging of Erdheim-Chester disease using FDG-PET/CT, NaF-PET/CT examinations, and skeletal scintigraphy. Regression of the disease after treatment with cladribine combined with cyclophosphamide and anakinra.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

From progression to complete remission - a case study of successful pemigatinib treatment in a patient with metastatic FGFR2+ cholangiocarcinoma.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Second and subsequent lines of systemic therapy in endometrial cancer - a real-life clinical experience.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Chronic low-grade fever or fever with mild lymphadenopathy may indicate Castleman disease if no malignant, autoimmune, or infectious cause of the lymphadenopathy is identified.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
Same journal

Clinical presentations of the most common histiocytic disorders.

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Multiple myeloma.

R Hájek1, M Krejcí, L Pour

  • 1Department of Internal Medicine-Hematooncology, University Hospital Brno, Czech Republic. r.hajek@fnbrno.cz

Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti
|September 20, 2011
PubMed
Summary
This summary is machine-generated.

This manuscript introduces multiple myeloma, covering its definition, incidence, etiology, pathogenesis, and diagnostic and treatment principles. It aligns with Czech Hematological Society guidelines for myeloma care.

More Related Videos

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
10:04

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

Area of Science:

  • Hematology
  • Oncology

Background:

  • Multiple myeloma is a hematologic malignancy with significant global incidence.
  • Understanding its etiology and pathogenesis is crucial for effective management.

Purpose of the Study:

  • To provide a concise introduction to multiple myeloma.
  • To outline the key aspects of its definition, incidence, etiology, pathogenesis, diagnostics, and treatment.

Main Methods:

  • Literature review and synthesis of current knowledge.
  • Alignment with established diagnostic and treatment guidelines.

Main Results:

  • A comprehensive overview of multiple myeloma is presented.
  • Key principles for diagnosis and treatment are briefly described.

Conclusions:

  • This work serves as a foundational resource for understanding multiple myeloma.
  • It emphasizes adherence to current clinical guidelines for patient care.